AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed.
AZN Key Statistics
AZN News
AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...
AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Analyst ratings
78%
of 32 ratingsMore AZN News
AstraZeneca (AZN) and Amgen’s (AMGN) Tezspire has been approved in the European Union, EU, as an add-on therapy with intranasal corticosteroids for the treatmen...
(RTTNews) - AstraZeneca (AZN) and Amgen (AMGN) announced that Tezspire (tezepelumab) has received European Union approval as an add-on therapy with intranasal c...
An AstraZeneca executive says breast-cancer drugs that the company highlighted at an industry conference over the weekend could represent $10 billion worth of c...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) announce positive results from the DESTINY-Breast11 Phase III trial showed Enhertu followed by paclitaxel, trastuzu...
Three large drug companies shared new study results this week that point to more progress in breast cancer treatment. The news came during the European Society...
AstraZeneca's (AZN) Enhertu could help some breast cancer patients avoid surgery, according to a study unveiled Saturday at the European Society of Medical Onco...